SAN DIEGO, March 31, 2011 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (“Apricus Bio”) (Nasdaq:APRI), announced today that the Mexican Patent Office (“MPO”) will grant an additional patent for Vitaros®, the Company’s topical alprostadil-based cream for the treatment of erectile dysfunction (“ED”).
